Published on 18 Mar 2024 on New Jersey Business Magazine
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics
Bristol Myers Squibb (BMS) has successfully completed its acquisition of Karuna Therapeutics, Inc....
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics
Bristol Myers Squibb (BMS) has successfully completed its acquisition of Karuna Therapeutics, Inc...
Loss-Making Karuna Therapeutics, Inc. (NASDAQ:KRTX) Expected To Breakeven In The Medium-Term
With the business potentially at an important milestone, we thought we'd take a closer look at Ka...
Karuna Therapeutics set to merge with Bristol-Myers Squibb By Investing.com
The waiting period under the Hart-Scott-Rodino Antitrust Improvement Act of 1976 (HSR Act), which...
Chief Medical Officer Stephen Brannan Sells 5,000 Shares of Karuna Therapeutics Inc (KRTX)
Karuna Therapeutics Inc (NASDAQ:KRTX), a clinical-stage biopharmaceutical company focused on deve...
Karuna's (KRTX) Q4 Loss Widens, Focus on Bristol Myers Buyout
Karuna Therapeutics, Inc. KRTX reported a loss of $3.01 per share in fourth-quarter 2023, wider t...
Decoding Karuna Therapeutics Inc (KRTX): A Strategic SWOT Insight
Strengths: Innovative CNS-focused pipeline with lead candidate KarXT showing promise in clinical ...
AbbVie Eyes Selling at Least $13 Billion of Bonds to Fund M&A
(Bloomberg) -- Pharmaceutical giant AbbVie Inc. is looking to sell at least $13 billion of corpor...
Systemic Risk Concerns Grow Among Money Managers as Real Estate Woes Cause Turmoil
(Bloomberg) -- Fears of a systemic credit event are growing among fund managers as alarms sound i...
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space - Biohaven (NYSE:BHVN)
RBC Capital Markets has initiated Biohaven Ltd BHVN, noting optimized development across programs...
Dip Buyers Wade Back In to Fuel Wall Street Gains: Markets Wrap
(Bloomberg) -- A renewed wave of dip buying sent stocks and bonds higher, following a slide trigg...